Please ensure Javascript is enabled for purposes of website accessibility
Home / AP News / CVS Health tops 2Q forecasts, downplays help from rebates

CVS Health tops 2Q forecasts, downplays help from rebates

CVS Health detailed a better-than-expected second quarter Wednesday and then reassured investors that it doesn't depend heavily on much-criticized prescription drug rebates that regulators may eliminate. Shares of the drugstore chain and pharmacy benefit manager climbed after CEO Larry Merlo told analysts that rebates from drugmakers will amount to only about 3 percent of the company's ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*